Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by highoutputon Jun 24, 2020 12:13pm

66 Views

Post# 31186119

RE:No worries.....can't post now as I'm working on t.FVL :)

You have been talkin about the science since it was 50 cents. What science are you talking about?

this stock is about to 6-7 cents in 2 weeks.

then it will go to zero. if i were you i would abandon ship. I will not be buying anymore as i jumped ship at 35.

but enjoy seeing you pump this dirty old dog haha

Bullboard Posts

Gold vs. bitcoin, where should you invest?